Literature DB >> 18937899

Omega-3 fatty acids: how can they be used in secondary prevention?

Konstantinos Tziomalos1, Vasilios G Athyros, Asterios Karagiannis, Dimitri P Mikhailidis.   

Abstract

Omega-3 fatty acids (FAs) are divided into long-chain fatty acids (eicosapentaenoic acid and docosahexaenoic acid ), which are found in fatty fish, and intermediate-chain FAs (alpha-linolenic acid), which are found in vegetable oils. Omega-3 FAs favorably modulate a variety of vascular risk factors and also exert antiarrhythmic effects. Epidemiologic data suggest that increased consumption of marine omega-3 FAs is associated with reduced coronary heart disease (CHD) mortality. Randomized controlled studies also show that supplementation with EPA and DHA reduces CHD risk, primarily in the secondary prevention setting. Data are more limited on the efficacy of marine omega-3 FAs for the primary prevention of CHD and on the role of alpha-linolenic acid. Increased intake of EPA and DHA represents a valuable tool for vascular disease prevention and should be recommended in all patients with CHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937899     DOI: 10.1007/s11883-008-0079-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  94 in total

1.  Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome.

Authors:  Noriko Satoh; Akira Shimatsu; Kazuhiko Kotani; Naoki Sakane; Kazunori Yamada; Takayoshi Suganami; Hideshi Kuzuya; Yoshihiro Ogawa
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

Review 2.  Atherogenesis in renal patients: a model of vascular disease?

Authors:  Georgios Efstratiadis; Konstantinos Tziomalos; Dimitri P Mikhailidis; Vasilios G Athyros; Apostolos Hatzitolios
Journal:  Curr Vasc Pharmacol       Date:  2008-04       Impact factor: 2.719

3.  Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial.

Authors:  J H Christensen; P Gustenhoff; E Korup; J Aarøe; E Toft; J Møller; K Rasmussen; J Dyerberg; E B Schmidt
Journal:  BMJ       Date:  1996-03-16

4.  Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD.

Authors:  Arja T Erkkilä; Nirupa R Matthan; David M Herrington; Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2006-09-18       Impact factor: 5.922

5.  Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia.

Authors:  Elsa M Hjerkinn; Ingebjørg Seljeflot; Ingrid Ellingsen; Paula Berstad; Ingvar Hjermann; Leiv Sandvik; Harald Arnesen
Journal:  Am J Clin Nutr       Date:  2005-03       Impact factor: 7.045

6.  Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors.

Authors:  Alison M Hill; Jonathan D Buckley; Karen J Murphy; Peter R C Howe
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

Review 7.  Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies.

Authors:  Alicia Montanez; Jeremy N Ruskin; Patricia R Hebert; Gervasio A Lamas; Charles H Hennekens
Journal:  Arch Intern Med       Date:  2004-05-10

8.  Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency.

Authors:  J Eritsland; H Arnesen; K Grønseth; N B Fjeld; M Abdelnoor
Journal:  Am J Cardiol       Date:  1996-01-01       Impact factor: 2.778

9.  (N-3) fatty acids do not affect electrocardiographic characteristics of healthy men and women.

Authors:  Anouk Geelen; Ingeborg A Brouwer; Peter L Zock; Jan A Kors; Cees A Swenne; Martijn B Katan; Evert G Schouten
Journal:  J Nutr       Date:  2002-10       Impact factor: 4.798

10.  Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries.

Authors:  Peter Angerer; Wolfgang Kothny; Stefan Störk; Clemens von Schacky
Journal:  Cardiovasc Res       Date:  2002-04       Impact factor: 10.787

View more
  4 in total

1.  Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

2.  Effects of eicosapentaenoic acid and vitamin C on glycemic indices, blood pressure, and serum lipids in type 2 diabetic Iranian males.

Authors:  Mohammad Mehdi Shakouri Mahmoudabadi; Mahmoud Djalali; Seyed Abolghassem Djazayery; Seyed Ali Keshavarz; Mohammad Reza Eshraghian; Ali Akbar Saboor Yaraghi; Gholamreza Askari; Reza Ghiasvand; Mahnaz Zarei
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

3.  The alpha linolenic acid content of flaxseed is associated with an induction of adipose leptin expression.

Authors:  Richelle S McCullough; Andrea L Edel; Chantal M C Bassett; Renée K Lavallée; Elena Dibrov; David P Blackwood; Bradley P Ander; Grant N Pierce
Journal:  Lipids       Date:  2011-10-27       Impact factor: 1.880

4.  Patient with hypertriglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 Fatty Acid ethyl esters.

Authors:  Vasilios G Athyros; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2012-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.